Medtronic has issued an “Urgent Medical Device Correction” about the accuracy of insulin pump delivery during changes in air pressure, such as airplane takeoffs and landings.

The US Food and Drug Administration (FDA) has issued a Class I tag to Medtronic’s recall of its MiniMed insulin pumps after the manufacturer noticed battery life issues earlier this year.

The pairing of Abbott's leading FreeStyle Libre technology with Medtronic's AID algorithms could enable automatic insulin adjustment for Type 1 and Type 2 diabetics to keep glucose in range.

EOFlow's flagship product is the EOPatch® device, a wearable insulin patch pump that provides continuous insulin delivery for people with diabetes.

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 ...

Patients urged to carry extra batteries as Medtronic recall affects 24,595 insulin pumps that may stop delivering insulin sooner than expected.

Medtronic Plc announced a voluntary recall Friday of certain insulin pumps after customers said a single drop, bump, or physical impact could shorten their battery life. The Galway, Ireland-based ...

Medtronic has announced that its long-awaited 780G diabetic therapy system has gained FDA approval which includes support for iPhone and Apple Watch monitoring.

Medtronic, which develops, manufactures and sells medical therapy devices, has issued a voluntary recall of its MiniMed 600 series or 700 series insulin pumps due to the pump's potentially shortened ...

Medtronic issued a recall on its MiniMed insulin pumps following reports of battery life issues that may lead to insulin delivery stoppages.

Insulet Corporation (PODD) and Tandem Diabetes (TNDM) traded lower Thursday after Medtronic (MDT) agreed to buy a Korean maker of insulin pumps. Read more here.